Vir Biotechnology Inc
Ownership
Ownership Structure
Who owns Vir Biotechnology Inc (VIR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.7% of the shares are freely tradable; institutional investors hold 81.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 12.22 | 20,678,283 | +14.9 | 06/30/2026 |
| ARCH VENTURE CORP | 7.50 | 12,694,163 | -1.7 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 6.79 | 11,495,215 | +24.7 | 06/30/2026 |
| SB INVESTMENT ADVISERS (UK) LTD | 6.47 | 10,948,093 | +0.0 | 06/30/2026 |
| State Street Corp | 5.89 | 9,964,151 | +39.5 | 06/30/2026 |
| GSK PLC | 5.05 | 8,550,954 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.78 | 6,388,775 | +18.7 | 06/30/2026 |
| Point72 Asset Management, L.P. | 3.35 | 5,666,821 | +190.3 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 4.46 | 7,551,878 | +0.0 | 09/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.88 | 4,872,331 | +0.5 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| More Robert J | Director | 517,917 | 5,697,087 $ | Aug 11, 2026 | indirect |
| Topalian Suzanne Louise | Director | 12,731 | 140,041 $ | Oct 27, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 27, 2026 | Topalian Suzanne Louise | Director | Other | 4,731 | 0.00 | – |
| Oct 27, 2026 | Topalian Suzanne Louise | Director | Other | 8,000 | 0.00 | – |
| Aug 11, 2026 | More Robert J | Director | Other | 8,000 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.